Angiogenesis and Cancer Microenvironment Laboratory, Univ. Bordeaux, Inserm U1029, Pessac, France.
Department of Clinical Pharmacology, Bordeaux University Hospital, Univ. Bordeaux, Inserm U1219, Bordeaux, France.
JAMA Oncol. 2021 May 1;7(5):775-778. doi: 10.1001/jamaoncol.2021.0210.
This pharmacovigilance study uses data from the World Health Organization database of adverse drug reactions to examine the association of antiangiogenic drugs with artery dissections or aneurysms among patients receiving antiangiogenic drugs for the treatment of cancer.
这项药物警戒研究利用世界卫生组织药物不良反应数据库的数据,研究接受抗血管生成药物治疗癌症的患者中,抗血管生成药物与动脉夹层或动脉瘤之间的关联。